FORA Capital’s Tourmaline Bio TRML Stock Holding History

FORA Capital’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,087	Closed	-$865K	–	654
2025 Q3	$865K	Buy	+18,087	New	+$502K	0.15%	188

FORA Capital's TRML Position: Q4 2025 in Review

FORA Capital sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 18,087 shares — an estimated $865K sold.

FORA Capital first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $865K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

FORA Capital reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
FORA Capital sold 18,087 Tourmaline Bio shares in Q4 2025, an estimated $865K.
FORA Capital first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
FORA Capital's Tourmaline Bio position peaked at $865K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on FORA Capital's 13F filing for Q4 2025, filed 13 Feb 2026.